Hepatitis C, Chronic
Item
diagnosis of chronic hepatitis c
boolean
C0524910 (UMLS CUI [1])
Hepatitis C virus genotype
Item
hcv genotype 1
boolean
C1533728 (UMLS CUI [1])
Body mass index
Item
bmi 18-38 kg/m2
boolean
C1305855 (UMLS CUI [1])
Therapy non-responder Pegylated interferon alfa | Therapy non-responder Ribavirin
Item
null responder to pegylated interferon alpha and ribavirin
boolean
C0919875 (UMLS CUI [1,1])
C0907160 (UMLS CUI [1,2])
C0919875 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
HBV coinfection | HIV coinfection
Item
co-infection with hepatitis b virus (hbv) or human immunodeficiency virus (hiv)
boolean
C2242656 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
Liver disease In addition to Hepatitis C
Item
significant liver disease in addition to hepatitis c
boolean
C0023895 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
Decompensated liver disease Medical History | Decompensated liver disease Features Clinical
Item
decompensated liver disease medical history or current clinical features
boolean
C4075847 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C4075847 (UMLS CUI [2,1])
C1521970 (UMLS CUI [2,2])
C0205210 (UMLS CUI [2,3])
Liver Cirrhosis
Item
histologic evidence of hepatic cirrhosis
boolean
C0023890 (UMLS CUI [1])
Comorbidity Clinical Significance | Exception Chronic Hepatitis C
Item
concurrent clinically significant medical diagnosis (other than chc)
boolean
C0009488 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0524910 (UMLS CUI [2,2])
Social Conditions Concurrent | Drug abuse | Alcohol intake above recommended sensible limits | Living conditions unsatisfactory
Item
concurrent social conditions (e.g. drugs of abuse, alcohol excess, poor living accommodation)
boolean
C0037403 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2])
C0560219 (UMLS CUI [3])
C0337630 (UMLS CUI [4])
Illness Clinical Significance
Item
clinically significant illness within 30 days preceding entry into the study
boolean
C0221423 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Study Subject Participation Status | Investigational New Drugs
Item
participated in an investigational drug study within 30 days or 5 half-lives, whichever is longer, prior to the start of study medication
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Drug Allergy
Item
history of clinically significant allergic drug reactions
boolean
C0013182 (UMLS CUI [1])